HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 300 filers reported holding HAEMONETICS CORP in Q4 2019. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $791,000 | +4.8% | 6,271 | 0.0% | 0.03% | +3.6% |
Q2 2019 | $755,000 | +37.5% | 6,271 | 0.0% | 0.03% | +27.3% |
Q1 2019 | $549,000 | -8.0% | 6,271 | +5.0% | 0.02% | -18.5% |
Q4 2018 | $597,000 | -12.7% | 5,971 | 0.0% | 0.03% | +8.0% |
Q3 2018 | $684,000 | +63.2% | 5,971 | +27.8% | 0.02% | +47.1% |
Q2 2018 | $419,000 | +22.5% | 4,671 | 0.0% | 0.02% | +21.4% |
Q1 2018 | $342,000 | +26.2% | 4,671 | 0.0% | 0.01% | +27.3% |
Q4 2017 | $271,000 | +52.2% | 4,671 | +17.6% | 0.01% | +37.5% |
Q3 2017 | $178,000 | +31.9% | 3,971 | +16.6% | 0.01% | +14.3% |
Q2 2017 | $135,000 | +75.3% | 3,407 | +79.3% | 0.01% | +75.0% |
Q1 2017 | $77,000 | +6.9% | 1,900 | +5.6% | 0.00% | 0.0% |
Q4 2016 | $72,000 | +10.8% | 1,800 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $65,000 | -94.9% | 1,800 | -93.6% | 0.00% | -80.0% |
Q2 2016 | $1,269,000 | +292.9% | 28,017 | +203.7% | 0.02% | +300.0% |
Q1 2016 | $323,000 | -18.6% | 9,225 | -25.0% | 0.01% | -16.7% |
Q4 2015 | $397,000 | +242.2% | 12,300 | +241.7% | 0.01% | +200.0% |
Q3 2015 | $116,000 | – | 3,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |